Windlas Biotech Ltd.

WINDLAS

₹1020.5

-0.38% (-3.9)

Market Cap

₹2,147 Cr.

P/E

34.79

About

Windlas Biotech Limited is a leading player in the pharmaceutical formulations CDMO industry in India, offering pharmaceutical development and large-scale manufacturing services. With expertise in sol… Read more

Windlas Biotech Limited is a leading player in the pharmaceutical formulations CDMO industry i… Read more

Low

496

52W Range

High

1198

Timeline

Key company specific updates

Company Timeline

Subscribe now for more updates

Custom financial statementNew

Edit rows

Forensics

9 Yes

Positive for this company

2 Neutral

Neutral for this company

4 No

Negative for this company

2 No Data

Insufficient data to analyse

Accounting & Shareholding

Depreciation Effect

Depreciation accounting is not leading to increase in profits
Other Income

Other income is not affecting ratios of the company
Pledge

Promoters have not pledged a significant portion of their holding
Retail Holding

Retail has been selling the stock which is usually a good time to buy
Revenue Recognition

Company is converting accounting profit to cash
Promoter Holding

Promoter has not sold any shares in the last 90 days
Contingent Liabilities

Unable to calculate due to limited data

Price & Performance

Capex vs ROCE

Roce of the company has increased over the last three years
ROE

Net profit margin is responsible for roe increase over last 10 years
Working Capital

Working capital of the company seems to be under control
Debt

Company should not have issues servicing its debt
Balance Sheet Strength

Balance sheet of the company is strong. but it might have issues paying it suppliers
Current vs Historic Valuation

Company is trading at a premium to 3yr historic valuations
Share price

Share price has increased over last 10 years but more due to rerating
Margin Stability

Margins of the company are volatile
ROCE Strength

Roce of the company is not consistently strong
Sales Growth

Unable to calculate due to limited data

Revenue mix

Product Wise Break-Up

Location Wise Break-Up

Acute vs Chronic

Segment Wise Break-Up

Peer Comparison

Corporate Actions

Consolidated

DATE

DETAILS

Show Less

FAQs on Windlas Biotech Ltd. Business

What does Windlas Biotech do?

Windlas Biotech Limited is a leading pharmaceutical CDMO company in India, offering a wide range of development and manufacturing services of high-quality and cost-effective products globally, along with branded products in trade generics and OTC markets.

Who are the competitors of Windlas Biotech?

Windlas Biotech major competitors are Vimta Labs, Indoco Remedies, IOL Chem & Pharma, Amrutanjan Healthcar, Bajaj Healthcare, Senores Pharmaceutic, SMS Pharmaceuticals.
Market Cap of Windlas Biotech is ₹2,147 Crs.
While the median market cap of its peers are ₹2,129 Crs.

Is Windlas Biotech financially stable compared to its competitors?

Windlas Biotech seems to be financially stable compared to its competitors.
The probability of it going bankrupt or facing a financial crunch seem to be lower than its immediate competitors.

View FAQ's On Shareprice

Global Leaders

Companies with a dominant global position in a product. Might be a sign of very strong moat.

Run Query

Company Filing

	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011	2010
Annual Report	FY25	FY24	FY23	FY22	FY21	FY20	FY19	FY18	FY17	FY16	FY15	FY14	FY13	FY12	FY11	FY10
Earnings Release		Mar Jun Sep Dec	Sep Dec
Investor Presentation		Mar Jun Sep Dec	Feb Mar May Jun Sep Dec	Feb Mar May Jun Aug Sep Nov	Jun Sep Dec
Conference Call		Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep	Sep Dec
Conference Call SummaryCon Call Summary Powered by Gemini

Discussions & Analysis

Windlas Biotech Ltd.

View the discussion on ValuePickr

Detailed Thread On Windlas Biotech - Ishan Tanna

Windlas Biotech Ltd Analysis - Congruence Advisers

Ideas Dashboard

Timeline

Watchlist

Portfolio

Alerts

Research

Stock Screener

Market

Raw Material

Windlas Biotech Ltd.